MicroRNA-31 Negatively Regulates Interleukin-34 Expression In Vitro

Area of Science:

• Molecular Biology
• Cell Biology
• Immunology

Background:

• Interleukin-34 (IL-34) is a cytokine crucial for macrophage development.
• Previous research indicated 1α,25-Dihydroxyvitamin D3 upregulates IL-34 in neural cells.
• The role of microRNAs in regulating IL-34 expression remained unclear.

Purpose of the Study:

• To investigate the regulatory role of microRNA-31 (miR-31) on Interleukin-34 (IL-34) expression.
• To identify the binding site and mechanism of miR-31 action on IL-34 mRNA.

Main Methods:

• Bioinformatic analysis using TargetScan and MiRanda to predict miR-31 binding sites.
• Quantitative PCR (qPCR) to assess miR-31 and IL-34 mRNA levels.
• Luciferase reporter assays to confirm direct binding of miR-31 to the IL-34 3'UTR.
• Western blotting and AGO2-IP assays to evaluate post-transcriptional regulation.

Main Results:

• A conserved binding site for miR-31 was identified in the 3'UTR of IL-34 mRNA.
• miR-31 levels were inversely correlated with IL-34 mRNA levels across cell lines.
• miR-31 directly bound to the IL-34 3'UTR, leading to post-transcriptional repression in MGC-803 cells.
• miR-31 mimic decreased IL-34 expression, while a miR-31 inhibitor increased it in KYSE-45 and HT-29 cells.

Conclusions:

• MicroRNA-31 (miR-31) functions as a negative regulator of Interleukin-34 (IL-34) expression.
• The regulation occurs through direct binding of miR-31 to the 3'UTR of IL-34 mRNA.
• This study elucidates a novel post-transcriptional mechanism controlling IL-34 levels in vitro.